Yul Ri Chung
Overview
Explore the profile of Yul Ri Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
631
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han E, Choi H, Kwon H, Chung Y, Shin H, Kim E, et al.
Breast Cancer Res
. 2024 Dec;
26(1):180.
PMID: 39643914
Background: The tumor immune microenvironment, particularly tumor-infiltrating lymphocytes (TILs), plays a critical role in disease progression and treatment response in triple-negative breast cancers (TNBCs). This study was aimed to characterize...
2.
Bai K, Woo J, Kwon H, Chung Y, Suh K, Kim S, et al.
Lab Invest
. 2024 Jun;
104(8):102092.
PMID: 38857783
Recent studies have shown that novel antibody-drug conjugates (ADCs) can improve clinical outcomes in patients with HER2-low breast cancers. This study aimed to investigate alteration of HER2 status during breast...
3.
Han S, Kim M, Chung Y, Woo J, Choi H, Park S
Sci Rep
. 2022 Nov;
12(1):20367.
PMID: 36437379
Downregulation of human leukocyte antigen (HLA) class I is one mechanism of escaping anti-tumor immunity by tumor cells. This study was conducted to compare HLA class I expression in ductal...
4.
Woo J, Choi H, Kim M, Chung Y, Park S
Breast Cancer
. 2022 Nov;
30(1):156.
PMID: 36334184
No abstract available.
5.
Park J, Chung Y, Nose A
Sci Rep
. 2022 Jul;
12(1):12218.
PMID: 35851285
Deep learning-based approaches in histopathology can be largely divided into two categories: a high-level approach using an end-to-end model and a low-level approach using feature extractors. Although the advantages and...
6.
Woo J, Choi H, Kim M, Chung Y, Park S
Breast Cancer
. 2022 Apr;
29(5):814-824.
PMID: 35451796
Background: MicroRNAs (miRNAs) control diverse biologic processes during tumor progression. This study was conducted to identify miRNAs that are implicated in progression of in situ to invasive breast cancer (IBC)...
7.
Kim M, Choi H, Woo J, Chung Y, Park S
Sci Rep
. 2021 Sep;
11(1):18007.
PMID: 34504204
Tumor immune microenvironment plays a crucial role in tumor progression. We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the...
8.
Chung Y, Woo J, Ahn S, Kang E, Kim E, Jang M, et al.
Sci Rep
. 2021 Jun;
11(1):12128.
PMID: 34108561
Prognostic implications of therapeutic response of metastatic lymph nodes (LNs) to neoadjuvant chemotherapy (NAC) remain unclear in patients with breast cancer. We aimed to evaluate the prognostic value of axillary...
9.
Park J, Chung Y, Kong S, Kim Y, Park H, Kim K, et al.
Sci Rep
. 2021 Feb;
11(1):2876.
PMID: 33536550
There have been substantial efforts in using deep learning (DL) to diagnose cancer from digital images of pathology slides. Existing algorithms typically operate by training deep neural networks either specialized...
10.
Park J, Jang B, Kim Y, Park H, Kim B, Kim M, et al.
Clin Cancer Res
. 2020 Nov;
27(3):719-728.
PMID: 33172897
Purpose: Gastric cancer remains the leading cause of cancer-related deaths in Northeast Asia. Population-based endoscopic screenings in the region have yielded successful results in early detection of gastric tumors. Endoscopic...